An opportunity for delegates to network, review posters and engage with exhibitors. 

Caroline Lamb, Chief Executive of NHS Scotland and Director-General Health and Social Care  

Professor Dame Anna Dominiczak, Chief Scientist (Health), Scottish Government and Regius Chair of Medicine, University of Glasgow

Chaired by former Chief Scientists (Health) Professor David Crossman and Professor Andrew Morris, this session will explore Scotland’s vibrant health and life science sector. It will evidence the value and impact of the CSO supported infrastructure in helping to deliver significant advances in healthcare, and support Scotland’s vision of becoming one of the most innovative small nations in the world.

• 09:35 – 09:50 - EAVE II (Early Pandemic Evaluation and Enhanced Surveillance of COVID-19) - Professor Sir Aziz Sheikh, Professor of Primary Care Research and Development and Director of the Usher Institute, University of Edinburgh
• 09:50 – 10:05 - Generation Scotland - Professor Heather Whalley, Chief Scientist, Generation Scotland and Professor of Neuroscience and Mental Health, University of Edinburgh
• 10:05 – 10:20 - Lessons learnt from Scotland's first Industrial Centre for AI Research in Digital Diagnostics (iCAIRD) - Dr Ken Sutherland, President, Canon Medical Research Europe; and James Blackwood, AI Strategy and Portfolio Lead, NHS Greater Glasgow and Clyde

Chaired by Professor Iain McInnes, Vice-Principal and Head of College of Medical, Veterinary and Life Sciences at University of Glasgow, this session will offer international insights from members of CSO Strategic Advisory Board.

• 10:30 - 10:50 - Health and Biomedical science research and innovation in Singapore: Looking back, looking forward - Professor TAN Chorh Chuan, Permanent Secretary (National Research & Development); Chairman, Agency for Science, Technology and Research; Chairman, MOH Office for Healthcare Transformation
• 10:50 - 11:10 - The Future of Health and Medicine - Dr Victor Dzau, President of US National Academy of Medicine (NAM), Vice Chair of the National Research Council, Chancellor Emeritus of Duke University

Chaired by Professor Sir Gregor Smith, Chief Medical Officer for Scotland, this panel discussion will spotlight research and innovation as a positive enabler for recovery, reform and sustainability in health and social care. It will explore how we harness the significant potential of our NHS, embed RDI across our health and care services and continuously maximise opportunities for improvement and growth.

Panel members:

• Caroline Lamb, Chief Executive of NHS Scotland and Director– General Health and Social Care
• Professor Tan Chorh Chuan Permanent Secretary (National Research & Development); Chairman, Agency for Science, Technology and Research; Chairman, MOH Office for Healthcare Transformation
• Dr Victor Dzau, President of US National Academy of Medicine (NAM), Vice Chair of the National Research Council, Chancellor Emeritus of Duke University
• Professor Andrew Morris, Director of Health Data Research UK, Vice-Principal of Data Science at the University of Edinburgh 

An opportunity for delegates to network, review posters and engage with exhibitors. 

Delegates can select a preferred thematic session during the registration process.

-------------------------------------------------------------------------------------- 

A: Precision Medicine

Described as the ‘Silicon Valley’ of Precision Medicine, this session will explore Scotland’s growing precision medicine ecosystem, supported by the multi-disciplinary expertise and capabilities of our universities and NHS, working proactively with industry. The session will showcase specific programmes of work, supported by Precision Medicine Alliance Scotland (PMAS) funding, that are tackling health conditions of major importance in Scotland, and positioning Scotland as one of the best places in the world to develop and deliver precision medicine.

B: Clinical Trials Showcase

Clinical research is the single most important way in which we improve our healthcare – by identifying new means to prevent, diagnose and treat disease. Emerging from the COVID-19 pandemic, significant work has been undertaken across Scotland to remobilise our portfolio of research across all phases, treatment types and conditions. This session will showcase the strength and diversity of the portfolio, the deep scientific expertise, and dedicated research infrastructure – all helping share a more resilient system for the future.

C: Powering healthcare through data and artificial intelligence (AI)

As we work to transform health experiences and outcomes, the need for rapid, real-time health information is essential and presents major opportunities to drive forward innovation and data-informed improvements in healthcare. Access to these enriched datasets, combined with an ability to apply AI and machine learning, can offer deeper patient insights, faster diagnosis and, ultimately, improved treatment. This session will outline work underway in Scotland to enhance our data and AI infrastructure, attract high-quality research and innovation projects and accelerate these evolving technologies into clinical service.

D: Enabling participation in research  

Patients and participants are the foundation of clinical research - without them research can’t happen, and healthcare can’t improve. Yet we know more needs to be done to ensure patients, their families and their carers are empowered to directly and proactively explore research opportunities and make informed decisions about participating in research that is of relevance to them. This session will explore the use of new services, new technologies and virtual delivery models to improve the way clinical research is accessed and delivered.

E: Strengthening patient and public involvement to shape research now and in the future 

Excellent public involvement is an essential part of health and social care research and shown to improve its quality and impact. Insights from lived experience, different aspirations and views on health outcomes ensure studies can be designed and delivered in more effective, relevant ways. This session will explore public involvement developments and examples of best practice to learn and demonstrate how we can continue to build public involvement in line with the UK Standards for Public Involvement.

An opportunity for delegates to network, review posters and engage with exhibitors. 

Chaired by Christine McLaughlin, Co-Director of Population Health, Scottish Government and Jane Grant, Chief Executive, NHS Greater Glasgow and Clyde, this session will explore how we work collaboratively to unlock and accelerate the full potential of Scotland, tackle major healthcare challenges, and identify the best treatments, technologies, and techniques for the benefit of our patients, our NHS, our economy and global profile.

• 14:20 - 14:40 - Changing the paradigm for health care systems - Professor Sir John Bell Regius Professor of Medicine University of Oxford member

14:40 - 15:55 - The end-to-end pathway for RDI across health and social care in Scotland: Building on a 50-year legacy of support, this session will explore unified efforts across Scotland to develop a highly collaborative, whole system approach to RDI, helping to deliver transformative changes in areas of national priority.   

• 14:45 - 14:55 - CSO Regional Innovation Hubs - Professor David Lowe, Clinical Director Health Innovation, Chief Scientist Office 
• 14:55 - 15:05 - Reducing Drug Deaths Innovation Challenge - Carrie Thomson, Programme Lead Innovation Collaboration, Chief Scientist Office 
• 15:05 - 15:20 - Accelerated National Innovation Adoption Pathway (ANIA) - Dr John Thomson, Associate Clinical Director, Centre for Sustainable Delivery; and Jason White, Head of Innovation at the NHS Centre for Sustainable Delivery
• 15:20 - 15:35 - Innovation Design Authority (IDA) - Tom Steele, Chair of Scottish Ambulance Service; and Professor Dame Anna Dominiczak, Chief Scientist (Health), Scottish Government and Regius Chair of Medicine, University of Glasgow
• 15:35 - 15:55 - Discussion

Chaired by Professor Jason Leitch, National Clinical Director of the Scottish Government, this engaging panel discussion will reflect on the need for Government, academia, industry, the NHS, and the public to be aligned and working collaboratively to collectively tackle healthcare challenges, offer unique expertise and attract investment into Scotland.

Panel members: 

• Professor Tan Chorh Chuan, Permanent Secretary (National Research & Development); Chairman, Agency for Science, Technology and Research; Chairman, MOH Office for Healthcare Transformation
• Dr Victor Dzau, President of US National Academy of Medicine (NAM), Vice Chair of the National Research Council, Chancellor Emeritus of Duke University
• Professor Sir John Bell, Regius Professor of Medicine University of Oxford
• Jane Grant, Chief Executive, NHS Greater Glasgow and Clyde
• Mark Logan, Chief Entrepreneur, Scottish Government
• Mark Cook, Chair of Life Sciences Industry Leadership Group

Professor Dame Anna Dominiczak, Chief Scientist (Health), Scottish Government and Regius Chair of Medicine, University of Glasgow

Abstract awards and an opportunity for delegates to network and reflect on learnings from the conference.